A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease

NCT01928420 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease
Dementia

Interventions

DRUG: Drug: NIC5-15
DRUG: Placebo

Sponsor

Humanetics Corporation

Collaborators

[object Object]
[object Object]